OneOme (A Portfolio of Pharmacogenetics Assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

OneOme (A Portfolio of Pharmacogenetics Assets) General Information

Description

A portfolio of pharmacogenetics assets based in Minneapolis, Minnesota.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Minneapolis, MN 55413
  • United States
Primary Industry
Buildings and Property
Acquirer
Corporate Office
  • Minneapolis, MN 55413
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OneOme (A Portfolio of Pharmacogenetics Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OneOme (A Portfolio of Pharmacogenetics Assets)‘s full profile, request access.

Request a free trial

OneOme (A Portfolio of Pharmacogenetics Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OneOme (A Portfolio of Pharmacogenetics Assets)‘s full profile, request access.

Request a free trial

OneOme (A Portfolio of Pharmacogenetics Assets) FAQs

  • Where is OneOme (A Portfolio of Pharmacogenetics Assets) headquartered?

    OneOme (A Portfolio of Pharmacogenetics Assets) is headquartered in Minneapolis, MN.

  • What industry is OneOme (A Portfolio of Pharmacogenetics Assets) in?

    OneOme (A Portfolio of Pharmacogenetics Assets)’s primary industry is Buildings and Property.

  • Is OneOme (A Portfolio of Pharmacogenetics Assets) a private or public company?

    OneOme (A Portfolio of Pharmacogenetics Assets) is a Private company.

  • What is OneOme (A Portfolio of Pharmacogenetics Assets)’s current revenue?

    The current revenue for OneOme (A Portfolio of Pharmacogenetics Assets) is .

  • Who are OneOme (A Portfolio of Pharmacogenetics Assets)’s investors?

    OneOme has invested in OneOme (A Portfolio of Pharmacogenetics Assets).

  • When was OneOme (A Portfolio of Pharmacogenetics Assets) acquired?

    OneOme (A Portfolio of Pharmacogenetics Assets) was acquired on 24-Nov-2025.

  • Who acquired OneOme (A Portfolio of Pharmacogenetics Assets)?

    OneOme (A Portfolio of Pharmacogenetics Assets) was acquired by Tempus AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process